Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.2570
Abstract: 2570Background: ABBV-075 is an oral small molecule inhibitor of the BET family of bromodomain-containing proteins that function as regulators controlling many transcriptional programs required for ...
read more here.
Keywords:
expression cytokine;
cytokine modulation;
gene expression;
abbv 075 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12872
Abstract: Background/Aim: The therapeutic potential of bromodomain and extra-terminal motif (BET) inhibitors in hematological cancers has been well established in preclinical and early-stage clinical trials, although as of yet, no BETtargeting agent has achieved approval. To…
read more here.
Keywords:
bet;
mivebresib abbv;
abbv 075;
clinical modeling ... See more keywords